Dr. Lan Zhang is the director of Pharmacology in Xuan-wu hospital of Capital Medical University (CMU).
She obtained her MD. in 1996 and PhD. in Pharmacology in 2005 from CMU. Dr. Zhang received a postdoctoral fellow in the department of Neruo-chemistry of New York State Basic research institute in 2007 and performed the research of the drug intervention on tau hyperphosphorylation.
Dr. Zhang is the top scientist of neuropharmacology in China. She leads the pharmacological research of Alzheimer’s disease and other neurodegenerative diseases in China. She was in charge of many important national projects about the drug therapy on the neurodegenerative disease, especially the R&D of the new drug on Alzheimer’s disease treatment. She have published more than 100 scientific papers and obtained 12 Chinese patents and 2 US patent for new drugs. She won the many academic awards in the field of Pharmacology and Neuroscience in China.
Dr. Zhang was the vice-chairman and secretary-general of Beijing Pharmacological society, and was elected as the fellow of many state academic associations such as Chinese pharmacological society, Chinese Pharmacy society, Chinese gerontology society, and so on.    

Representative Publications:
1.    Lan Zhang*, Cong Shen, Jin Chu, Ying Liu, Yali Li, Li Zhang, Lin Li. Icariin reduces α-synuclein over-expression by promoting α-synuclein degradation. AGE, 2015，37(4): 9811.  DOI 10.1007/s11357-015-9811-z
2.    Lan Zhang, Cong Shen, Jin Chu, Ruyi Zhang, Yali Li, Lin Li. Icariin decreases the expression of APP and BACE-1 and reduces the β-amyloid burden in an APP transgenic mouse model of Alzheimer’s disease. International Journal of Biological Sciences, 2014, 10(2):181-191. doi: 10.7150/ijbs.6232
3.    Cong Shen, Fang-ling Sun, Ru-yi Zhang, Lan Zhang*, Lin Li*. Tetrahydroxystilbene glucoside ameliorates memory and movement functions, protects synapses and inhibits alpha-synuclein aggregation in hippocampus and striatum in aged mice. Restorative Neurology and Neuroscience, 2015,33(4): 531-541.
4.    Cui-cui Yang, Lin Li, Sha-sha Zheng, Jie Lu, Li Zhang, Ya-li Li, Lan Zhang*. Cornel iridoid glycoside reduces infarct size measured by magnetic resonance imaging and improves neurological function after focal cerebral ischemia in rats. Chin J Integr Med. 2015 Aug 11. doi：10.1007/s11655-015-2288-x
5.    Cui-cui Yang, Xue-xian Kuai,Wen-bin Gao, Jian-chun Yu, Qi Wang, Lin Li, Lan Zhang*. Morroniside-induced PP2A activation antagonizes tau hyperphosphorylation in a cellular model of neurodegeneration. J Alzheimers Dis. 2016, Jan 13, 51（1）：33-44, DOI: 10.3233/JAD-150728